Turbulence in Global Markets Amid Middle East Conflicts
Source: Devdiscourse
15 May 2026
Health X Platform Limited (formerly known as sastasundar ventures Limited) has informed the stock exchanges of the completion of the transfer of the entire equity stake held by Mitsubishi Corporation in Sastasundar Healthbuddy Limited, a material subsidiary of the Company, to Envision India Fund. The transaction was completed on May 12, 2026, following the earlier disclosure made on February 25, 2026, regarding the execution of a Share Purchase Agreement by Sastasundar Healthbuddy Limited.
Transaction Details
The completed transaction involved the transfer of Mitsubishi Corporation's full shareholding in Sastasundar Healthbuddy Limited. The key details of the transaction are outlined below:
Parameter: Details Shares Transferred: 10,13,766 (Ten Lakh Thirteen Thousand Seven Hundred Sixty-Six) equity shares Stake Transferred: 4.68% of total issued and paid-up share capital Seller: Mitsubishi Corporation Buyer: Envision India Fund Transaction Completion Date: May 12, 2026 Company Involved: Sastasundar Healthbuddy Limited (material subsidiary)
As a result of the transfer, Mitsubishi Corporation has ceased to be a shareholder of Sastasundar Healthbuddy Limited.
Board Acknowledgement and Regulatory Disclosure
The board of directors of Sastasundar Healthbuddy Limited took note of the said transfer at its board meeting held on May 15, 2026. Health X Platform Limited received the intimation from Sastasundar Healthbuddy Limited on May 15, 2026, at 10:46 AM. The disclosure has been made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The intimation was submitted by Pratap Singh, Company Secretary and Compliance Officer of Health X Platform Limited, in accordance with applicable regulatory requirements.
AI Summary
Health X Platform Limited, formerly known as Sastasundar Ventures Limited, has submitted a revised Chartered Accountants' certificate to BSE and NSE in support of its application to change the company name. The exchanges had requested a bifurcation of revenue to verify compliance with Regulation 45 of SEBI (LODR) Regulations, 2015. The statutory auditors' certificate confirms that more than fifty percent of the company's consolidated revenue is derived from healthcare activity, which aligns with the proposed new name. The company will send the revised certificate to shareholders at the next available opportunity through the Notice of General Meeting or other specified modes under the Companies Act, 2013.
powered by
Health X Platform Limited, formerly known as sastasundar ventures , has submitted a revised Chartered Accountants' certificate to BSE Limited and National Stock Exchange of India Limited in support of its application for changing the company name from "Sastasundar Ventures Limited" to "Health X Platform Limited." The intimation was made under Regulation 30 of the SEBI (Listing of Obligations and Disclosure Requirements) Regulations, 2015, dated 24-04-2026.
Regulatory Compliance
The stock exchanges had requested the company to furnish a bifurcation of revenue in the CA certificate to affirm compliance with conditions prescribed in Regulation 45 of the SEBI (LODR) Regulations, 2015. The revised certificate, issued by J K V S & Co., Chartered Accountants, confirms that the company has not changed its name in the preceding one-year period, satisfying Regulation 45(1)(a).
Revenue Bifurcation Details
The auditors certified that more than fifty percent of the total revenue of the company, on a consolidated basis, is through the activity suggested by the new name. The detailed bifurcation of revenue for the period from 1st January, 2025 to 31st December, 2025 is as follows:
From 1st January, 2025 to 31st December, 2025 Amount (Rs. in lakhs) Revenue from business activity - Healthcare Activity 1,20,971.84 Revenue from business activity - Financial Services activity 2,160.79 Total 1,23,132.63
The figures for the period have been taken from the limited review financial results filed by the company with the stock exchanges. Healthcare activity revenue constitutes approximately 98.25% of the total consolidated revenue.
Shareholder Communication
The original certificate was attached to the Postal Ballot Notice dated January 7, 2026, which was sent to the stock exchanges and dispatched to shareholders on January 13, 2026. The company will send the revised CA certificate to shareholders at the next available opportunity, either through the Notice of General Meeting or such other mode as specified in the Companies Act, 2013 read with SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015.
The statutory auditors' certificate was issued on April 9, 2026, by J K V S & Co., Firm Registration No. 318086E, with Utsav Saraf as the signing partner. The company's scrip codes are 533259 at BSE and SASTASUNDR at NSE.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.
Disclaimer:
The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.
